Business

BIOMERIEUX, biggest drop in the SRD market at mid-session on Tuesday April 7, 2020 –

Published on

Pixabay


(AOF) – BIOMERIOUS (- 5.82% to 101.90 euros)

The specialist in in vitro diagnostics is the victim of arbitrations in favor of values ​​abused by the Covid-19 pandemic. Since the start of the year, the share has gained almost 29%, the best performance of the SBF 120.

AOF – LEARN MORE

©
                                                        AOF

The AOF information reproduced on Capital.fr is extracted from the AOF information service.
This information is protected by intellectual property rights held by OPTION FINANCE SAS, publisher of the real-time stock market information service AOF, and its contributors.
Consequently, any reproduction, copy, duplication, modification, transfer, redistribution, translation, commercial exploitation or not, creation of hypertext link or reuse in any way of this information is subject to the prior written agreement of OPTION FINANCE SAS and its contributors.
AOF can be reached at the following address aof@optionfinance.fr
OPTION FINANCE SAS collects its data from sources it considers the most reliable. However, subject to gross negligence, OPTION FINANCES SAS and its contributors in no way guarantee the absence of error and defects, even hidden, nor the exhaustive nature or the lack of conformity to any use of these data and OPTION FINANCE SAS or one of its contributors, and cannot be held responsible for delays or interruptions that could affect access to them.
The user of the OPTION FINANCE SAS service will use the AOF data at his own risk and must hold OPTION FINANCE SAS and its contributors free from any claim resulting from this use.

Tags

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button
Close
Close